Headaches and Migraines during the COVID-19 Pandemic

A special issue of Brain Sciences (ISSN 2076-3425). This special issue belongs to the section "Behavioral Neuroscience".

Deadline for manuscript submissions: closed (30 September 2021) | Viewed by 5504

Special Issue Editor


E-Mail Website
Guest Editor
Applied Neurophysiology and Pain Unit, Basic Medical, Neuroscience and Sensory System Department, Policlinico General Hospital, Bari Aldo Moro University, 70100 Bari, Italy
Interests: headache; migraine; clinical neurophysiology; psychophysiology; cognitive neuroscience; neurodegenerative diseases
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

In this unprecedented time, chronic disease management is seriously compromised, the health situation negatively impacted by the pandemic. General distress due to viral diffusion could cause a worsening of chronic neurological diseases. In addition, several neurological symptoms could be a direct consequence of viral infection.

Migraine and primary headaches have a wide diffusion among general population. Chronic migraine is a highly disabling condition. The SARS-CoV-2 pandemic and consequent restrictive measures cause general distress, with potential worsening of migraines as an outcome. In addition, the overwork of the public health system could cause delay in diagnosis and appropriate treatment. Headaches, as a symptom, could be an early manifestation of viral infection and vaccine reaction, and it could probably persist over time after the acute disease has been resolved. The outcome of migraine in post-Covid syndrome is also presently unknown

The Special Issue aims to collect studies on the effect of general lifestyle changes during the pandemic on migraine and primary headaches, risk perception and headache, general management of primary headache during pandemic, headache symptoms in the acute viral infection, and the post vaccination phase.   

We are aimed to Cut-edge research topics as following: The outcome of migraine in Covid-19 post-infection; headache as a disabling condition during acute vaccine reaction; the effects of remote teaching on childhood headache.

Research studies, clinical trials, review, case reports, pilot studies all could submit to our issue.

Prof. Dr. Marina De Tommaso
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Brain Sciences is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • migraine
  • headache
  • Covid-19
  • restrictive measures
  • management
  • viral infection
  • vaccination

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

7 pages, 224 KiB  
Article
Headache Attributed to SARS-CoV-2 Infection or COVID-19 Related Headache—Not Migraine-like Problem-Original Research
by Aleksandra Kacprzak, Daniel Malczewski and Izabela Domitrz
Brain Sci. 2021, 11(11), 1406; https://doi.org/10.3390/brainsci11111406 - 25 Oct 2021
Cited by 8 | Viewed by 1489
Abstract
Background: Many studies have confirmed headache as one of the most common COVID-19-related neurological symptoms. There are some reports concerning migraine attacks during SARS-CoV-2 infection with an unusual course of migraine attack. Our aim was to recognize and characterize accurately the features of [...] Read more.
Background: Many studies have confirmed headache as one of the most common COVID-19-related neurological symptoms. There are some reports concerning migraine attacks during SARS-CoV-2 infection with an unusual course of migraine attack. Our aim was to recognize and characterize accurately the features of headaches accompanying this disease. Methods: Research based on questionnaire study gathered 100 randomly chosen medical healthcare employees who experienced symptoms associated with COVID-19 disease, 96 with confirmed COVID-19 (positive SARS-CoV-2 PCR laboratory test or positive rapid COVID-19 antigen test). Conclusion: Headaches reported in the study did not fulfill criteria for migraine with/without aura, tension-type headache according to ICHD-3. Full article
(This article belongs to the Special Issue Headaches and Migraines during the COVID-19 Pandemic)
9 pages, 956 KiB  
Article
Migraine during COVID-19: Data from Second Wave Pandemic in an Italian Cohort
by Eleonora Gentile, Marianna Delussi, Chiara Abagnale, Valeria Caponnetto, Francesco De Cesaris, Ilaria Frattale, Elena Guaschino, Andrea Marcinnò, Raffaele Ornello, Francesca Pistoia, Alessia Putortì, Giusy Candida, Fausto Roveta, Chiara Lupi, Gianluca Coppola, Addolorata Maria Pia Prudenzano, Innocenzo Rainero, Grazia Sances, Maria Elena Roca, Maria Trojano, Francesco Pierelli, Pierangelo Geppetti, Simona Sacco and Marina de Tommasoadd Show full author list remove Hide full author list
Brain Sci. 2021, 11(4), 482; https://doi.org/10.3390/brainsci11040482 - 10 Apr 2021
Cited by 14 | Viewed by 3204
Abstract
Objectives: The study aims to assess the impact of the second COVID-19 pandemic wave on migraine characteristics. Methods: This is an observational cross-sectional study conducted on migraine patients previously interviewed during the first Italian pandemic outbreak. A second structured telephone interview was conducted [...] Read more.
Objectives: The study aims to assess the impact of the second COVID-19 pandemic wave on migraine characteristics. Methods: This is an observational cross-sectional study conducted on migraine patients previously interviewed during the first Italian pandemic outbreak. A second structured telephone interview was conducted between 20 November 2020 and 18 January 2021. We compared migraine characteristics among T0 (before pandemic), T1 (during the first pandemic phase), and T2 (during the second pandemic phase). Results: Among the 433 patients interviewed during the first pandemic phase, 304 cases were finally considered. One hundred forty-eight patients had a control visit between March 2020 and December 2020, 120 had an in-person visit, 14 by phone, the remainder used telemedicine software provided by the hospital. Frequency of headache, number of symptomatic drugs and headache intensity worsened during T2, compared to T0 and T1, especially in episodic migraine. Headache intensity increased relating to the negative emotional impact of the pandemic. Migraine management during the pandemic did not influence the clinical outcome. Conclusion: The prolongation of the pandemic seems to have a negative impact on migraine evolution. The arousal and negative psychological behavior toward the COVID-19 outbreak seem to worsen migraine. Full article
(This article belongs to the Special Issue Headaches and Migraines during the COVID-19 Pandemic)
Show Figures

Figure 1

Back to TopTop